Showing results (531-540 of 2,462) with videos related to
Sort By:
Pageof 247
Journal of Gastrointestinal Oncology|March 14, 2024
Prediction and validation of circulating G-quadruplexes as a novel biomarker in colorectal cancerHui Zhang, Jing Zhou, Yingjiang YeJournal of Gastrointestinal Oncology|March 14, 2024
LncRNA PCAT6 is a predictor of poor prognosis of colorectal cancerLin Han, Zhuang Li, Peng Zhang, et al.Journal of Gastrointestinal Oncology|March 14, 2024
Prognostic nomogram in patients with gastrointestinal stromal tumors: a SEER-based studyPan Xu, Wei Ding, Feifei Zheng, et al.Journal of Gastrointestinal Oncology|March 14, 2024
BMP6 inhibits gastric cancer growth and predicts good prognosisChao Song, Mengmeng Liu, Ganggang Wang, et al.Journal of Gastrointestinal Oncology|March 14, 2024
Immune checkpoint blockade induced sarcoid-like reaction mimicking progression of disease in a patient with microsatellite instable colorectal cancer: case report and review of the literatureFergus Keane, Elizabeth Yogiaveetil, Brie Kezlarian, et al.Journal of Gastrointestinal Oncology|March 14, 2024
A prognostic nomogram integrating carcinoembryonic antigen levels for predicting overall survival in elderly patients with stage II-III colorectal cancerHaijiao Zhang, Rangrang Wang, Tianyu Yu, et al.Journal of Gastrointestinal Oncology|March 14, 2024
LINC01977 promotes colorectal cancer growth and metastasis by enhancing aerobic glycolysis via the ERK/c-Myc axisJie Wu, Qiwen Chen, Yunliang Wang, et al.Journal of Gastrointestinal Oncology|March 14, 2024
PD-1 inhibition combined with intensity-modulated radiotherapy, to better serve patients with retroperitoneal lymph node metastases from gastrointestinal cancerYunyun Lu, Zhengxuying Fang, Linglong Tao, et al.Journal of Gastrointestinal Oncology|May 17, 2024
Multiple primary tumors in patients with surgically treated pancreatic cancer: a SEER population-based studyMinghao Zhang, Nana Li, Kuanjie Ma, et al.Journal of Gastrointestinal Oncology|May 17, 2024
Efficacy and safety of gemcitabine plus raltitrexed or S-1 versus standard third-line therapies in metastatic colorectal cancer: a retrospective cohort studyJialong Tao, Yingtian Zhang, Yanjie Wang, et al.Pageof 247